Clinical Effect of Low Molecular Weight Heparin in the Treatment of Pregnant Women with Gestational Diabetes Mellitus Complicated with Dyslipidemia in the Second Trimester of Pregnancy
Objective To explore the clinical effect of low molecular weight heparin in the treatment of pregnant women with gestational diabetes mellitus(GDM)complicated with dyslipidemia in the second trimester of pregnancy.Methods A total of 80 pregnant women with GDM complicated with dyslipidemia in the second trimester of pregnancy who were examined and delivered in our hospital from October 2020 to December 2022 were selected and randomly divided into two groups,with 40 cases in each group.The control group was given routine treatment,and the study group was treated with low molecular weight heparin on the basis of the control group.The blood lipid levels,and maternal and infant outcomes were compared between the two groups.Results After treatment,the levels of HDL in the two groups were significantly higher than those before treatment,and the levels of LDL,TG and TC were significantly lower than those before treatment(P<0.05);The HDL level in the study group was significantly higher than that in the control group,and the levels of LDL,TG and TC were significantly lower than those in the control group(P<0.05).The total incidence of adverse maternal and infant outcomes in the study group was 7.50%,significantly lower than 25.00%in the control group(P<0.05).Conclusions Low molecular weight heparin in the treatment of pregnant women with GDM complicated with dyslipidemia in the second trimester of pregnancy has significant effect,which can obviously improve the blood lipid levels and reduce the occurrence risk of adverse maternal and infant outcomes.
Gestational diabetes mellitusDyslipidemiaLow molecular weight heparinBlood lipidMaternal and infant outcomes
国家科技期刊平台
NSTL
万方数据
